Internal balance sheet

Internal balance sheet 31.12.2022 31.12.2021
ASSETS
NON-CURRENT ASSETS

Intangible assets

Other long term expenses
Advance payments and uncompleted purchases

Intangible assets in total


5 345 224,33
72 021,31
5 417 245,64


3 533 551,70
468 928,86
4 002 480,56

Tangible assets

Other long term expenses
Machinery and equipment
Advance payments and uncompleted purchases

Tangible assets in total


1 949 978,58
4 035 406,31
385 457,61
6 370 842,50

57 802,97
2 664 064,97
2 921 536,23
5 643 404,17

Investments

Other shares and similar rights of ownership


1 558,60

1 558,60

CURRENT ASSETS

Inventories

Materials and accessories
Own products

Inventories in total


4 375 497,00
458 838,18
4 834 335,18

3 883 504,00
362 386,18
4 245 890,18

Long Term Receivables

Security deposits

832 017,23

832 017,23

Short term receivables

Accounts receivable
Group internal receivables
Other receivables
Accruals

Short term receivables in total

3 902 826,22
2 726,25

1 713 073,64
5 618 626,11


2 886 028,01
1,26

683,30

1 182 640,59
4 069 353,16

Financial instruments

Other shares and stock


50 685 049,16

55 386 309,31

Cash in hand and in bank

18 532 986,99

30 292 809,11

TOTAL ASSETS 92 292 661,41 104 473 822,32
EQUITY AND LIABILITIES
EQUITY
Blood Service Research Fund
Profit for previous financial years
Profit for the financial year
TOTAL EQUITY
22 472 097,43
71 918 829,99
-12 968 361,24
81 422 566,18
23 051 309,70
65 435 722,47
5 903 895,25
94 390 927,42

EXTERNAL LIABILITIES

Current

Accounts payable
Group internal liabilities
Other liabilities
Accruals

Current liabilities in total

 

 



4 789 331,26
313 989,51
451 191,79
5 315 582,67
10 870 095,23

 

 



4 749 706,88
172 567,12
411 154,24
4 749 466,66
10 082 894,90

 

 

TOTAL EQUITY AND LIABILITIES

92 292 661,41

104 473 822,32